Related references
Note: Only part of the references are listed.CellExpress: a comprehensive microarray-based cancer cell line and clinical sample gene expression analysis online system
Yi-Fang Lee et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2018)
Pharmacokinetics of neratinib during coadministration with lansoprazole in healthy subjects
Kiana Keyvanjah et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Label-Free Molecular Imaging of Biological Cells and Tissues by Linear and Nonlinear Raman Spectroscopic Approaches
Christoph Krafft et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Neratinib induces ErbB2 ubiquitylation and endocytic degradation via HSP90 dissociation in breast cancer cells
Yingqiu Zhang et al.
CANCER LETTERS (2016)
Stimulated Raman scattering microscopy: an emerging tool for drug discovery
W. J. Tipping et al.
CHEMICAL SOCIETY REVIEWS (2016)
Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Arlene Chan et al.
LANCET ONCOLOGY (2016)
Raman microscopy for cellular investigations - From single cell imaging to drug carrier uptake visualization
Birthe Kann et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Raman imaging of drug delivery systems
Geoffrey P. S. Smith et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Label-Free Raman Spectroscopic Imaging Monitors the Integral Physiologically Relevant Drug Responses in Cancer Cells
Samir F. El-Mashtoly et al.
ANALYTICAL CHEMISTRY (2015)
The Role of Extrahepatic Metabolism in the Pharmacokinetics of the Targeted Covalent Inhibitors Afatinib, Ibrutinib, and Neratinib
Yoshihiro Shibata et al.
DRUG METABOLISM AND DISPOSITION (2015)
Label-free imaging of drug distribution and metabolism in colon cancer cells by Raman microscopy
Samir F. El-Mashtoly et al.
ANALYST (2014)
Automated Identification of Subcellular Organelles by Coherent Anti-Stokes Raman Scattering
Samir F. El-Mashtoly et al.
BIOPHYSICAL JOURNAL (2014)
Imaging the intracellular distribution of tyrosine kinase inhibitors in living cells with quantitative hyperspectral stimulated Raman scattering
Dan Fu et al.
NATURE CHEMISTRY (2014)
Live-cell imaging of alkyne-tagged small biomolecules by stimulated Raman scattering
Lu Wei et al.
NATURE METHODS (2014)
Developments in preclinical cancer imaging: innovating the discovery of therapeutics
James R. W. Conway et al.
NATURE REVIEWS CANCER (2014)
Safety, Efficacy and Pharmacokinetics of Neratinib (HKI-272) in Japanese Patients with Advanced Solid Tumors: A Phase 1 Dose-escalation Study
Yoshinori Ito et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2012)
Pharmacokinetics of oral neratinib during co-administration of ketoconazole in healthy subjects
Richat Abbas et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Lecia V. Sequist et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Live Cell in Vitro and in Vivo Imaging Applications: Accelerating Drug Discovery
Beverley Isherwood et al.
Pharmaceutics (2011)
Label-free imaging of human cells: algorithms for image reconstruction of Raman hyperspectral datasets
Milos Miljkovic et al.
ANALYST (2010)
Label-Free Imaging of Metal-Carbonyl Complexes in Live Cells by Raman Microspectroscopy
Konrad Meister et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Cell Signaling by Receptor Tyrosine Kinases
Mark A. Lemmon et al.
CELL (2010)
A Single-Dose, Crossover, Placebo- and Moxifloxacin-Controlled Study to Assess the Effects of Neratinib (HKI-272) on Cardiac Repolarization in Healthy Adult Subjects
Bruce Hug et al.
CLINICAL CANCER RESEARCH (2010)
Analytical tools for the physicochemical profiling of drug candidates to predict absorption/distribution
Yveline Henchoz et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2009)
A Phase I Study with Neratinib (HKI-272), an Irreversible Pan ErbB Receptor Tyrosine Kinase Inhibitor, in Patients with Solid Tumors
Kwok-K. Wong et al.
CLINICAL CANCER RESEARCH (2009)
The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
Cai-Hong Yun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Early detection of cervical neoplasia by Raman spectroscopy
Philip R. T. Jess et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Label-free detection of mitochondrial distribution in cells by nonresonant Raman microspectroscopy
Christian Matthaus et al.
BIOPHYSICAL JOURNAL (2007)
Epidermal growth factor receptor mutations in lung cancer
Sreenath V. Sharma et al.
NATURE REVIEWS CANCER (2007)
Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib
EL Kwak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
W Pao et al.
PLOS MEDICINE (2005)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Share Paper
